Nu-Med Plus appoints Jeffrey L. Robins to Board of Directors

Nu-Med Plus, Inc.

On October 18, 2022, Board unanimously appointed Jeffrey L. Robins as an additional member.
Appointment fills a recognized need for increased board membership.
No other changes to officer positions or compensation disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey L. Robins

Director

NUMD · Nu-Med Plus, Inc.

Effective: 2022-10-18
Filed: October 21, 2022, 7:59 PM ET

On October 18, 2022, the Board of Directors recognized the need for an additional member of the Board of Directors, and unanimously consented to appoint Jeffrey L. Robins to the Board of Director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey L. Robins was appointed as Director at Nu-Med Plus, Inc..

Action: appointed
Role: Director

Exact text from the filing

On October 18, 2022, the Board of Directors recognized the need for an additional member of the Board of Directors, and unanimously consented to appoint Jeffrey L. Robins to the Board of Director.

View on SEC.gov

Nu-Med Plus, Inc. filing history →

Source: SEC EDGAR

accession 0001548123-22-000151

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.